Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 11

1.

Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.

Li YR, Li J, Zhao SD, Bradfield JP, Mentch FD, Maggadottir SM, Hou C, Abrams DJ, Chang D, Gao F, Guo Y, Wei Z, Connolly JJ, Cardinale CJ, Bakay M, Glessner JT, Li D, Kao C, Thomas KA, Qiu H, Chiavacci RM, Kim CE, Wang F, Snyder J, Richie MD, Flatø B, Førre Ø, Denson LA, Thompson SD, Becker ML, Guthery SL, Latiano A, Perez E, Resnick E, Russell RK, Wilson DC, Silverberg MS, Annese V, Lie BA, Punaro M, Dubinsky MC, Monos DS, Strisciuglio C, Staiano A, Miele E, Kugathasan S, Ellis JA, Munro JE, Sullivan KE, Wise CA, Chapel H, Cunningham-Rundles C, Grant SF, Orange JS, Sleiman PM, Behrens EM, Griffiths AM, Satsangi J, Finkel TH, Keinan A, Prak ET, Polychronakos C, Baldassano RN, Li H, Keating BJ, Hakonarson H.

Nat Med. 2015 Sep;21(9):1018-27. doi: 10.1038/nm.3933. Epub 2015 Aug 24.

2.

Juvenile spondyloarthritis.

Gmuca S, Weiss PF.

Curr Opin Rheumatol. 2015 Jul;27(4):364-72. doi: 10.1097/BOR.0000000000000185. Review.

3.

Update on juvenile spondyloarthritis.

Ramanathan A, Srinivasalu H, Colbert RA.

Rheum Dis Clin North Am. 2013 Nov;39(4):767-88. doi: 10.1016/j.rdc.2013.06.002. Epub 2013 Aug 24. Review.

4.

Double-blind, placebo-controlled randomized trial with adalimumab for treatment of juvenile onset ankylosing spondylitis (JoAS): significant short term improvement.

Horneff G, Fitter S, Foeldvari I, Minden K, Kuemmerle-Deschner J, Tzaribacev N, Thon A, Borte M, Ganser G, Trauzeddel R, Huppertz HI.

Arthritis Res Ther. 2012 Oct 24;14(5):R230. doi: 10.1186/ar4072.

5.

Both baseline clinical factors and genetic polymorphisms influence the development of severe functional status in ankylosing spondylitis.

Schiotis R, Bartolomé N, Sánchez A, Szczypiorska M, Sanz J, Cuende E, Collantes Estevez E, Martínez A, Tejedor D, Artieda M, Buzoianu A, Mulero J.

PLoS One. 2012;7(9):e43428. doi: 10.1371/journal.pone.0043428. Epub 2012 Sep 12.

7.

The contribution of disease activity on functional limitations over time through psychological mediators: a 12-month longitudinal study in patients with ankylosing spondylitis.

Jang JH, Green CE, Assassi S, Reveille JD, Ward MM, Weisman MH, Nicassio PM.

Rheumatology (Oxford). 2011 Nov;50(11):2087-92. doi: 10.1093/rheumatology/ker274. Epub 2011 Aug 28.

8.

Ankylosing spondylitis: patterns of radiographic involvement--a re-examination of accepted principles in a cohort of 769 patients.

Jang JH, Ward MM, Rucker AN, Reveille JD, Davis JC Jr, Weisman MH, Learch TJ.

Radiology. 2011 Jan;258(1):192-8. doi: 10.1148/radiol.10100426. Epub 2010 Oct 22.

9.

Classification of juvenile spondyloarthritis: Enthesitis-related arthritis and beyond.

Colbert RA.

Nat Rev Rheumatol. 2010 Aug;6(8):477-85. doi: 10.1038/nrrheum.2010.103. Epub 2010 Jul 6. Review.

10.

Inflammatory bowel disease serologies in ankylosing spondylitis patients: a pilot study.

Mundwiler ML, Mei L, Landers CJ, Reveille JD, Targan S, Weisman MH.

Arthritis Res Ther. 2009;11(6):R177. doi: 10.1186/ar2866. Epub 2009 Nov 23.

11.

Clinical and immunogenetic prognostic factors for radiographic severity in ankylosing spondylitis.

Ward MM, Hendrey MR, Malley JD, Learch TJ, Davis JC Jr, Reveille JD, Weisman MH.

Arthritis Rheum. 2009 Jul 15;61(7):859-66. doi: 10.1002/art.24585.

Supplemental Content

Support Center